Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: Can preoperative carcinoembryonic antigen level predict pathological stage?

Interactive Cardiovascular and Thoracic Surgery

Volumn 9, Issue 2, 2009, Pages 199-202

  Kawachi, Riken ^a   Nakazato, Yohko ^a   Takei, Hidefumi ^a   Koshi Ishi, Yoshihiko ^a   Goya, Tomoyuki ^a  

^a KYORIN UNIVERSITY   (Japan)

Author keywords

Carcinoembryonic antigen; Lung cancer; TNM classification

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

AGED; ARTICLE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

AGED; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 68049083613     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.206698     Document Type: Article

References (10)

1. Inoue M, Minami M, Shiono H, Sawabata N, Ideguchi K, Okumura M. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg 2006;131:988-993.
2. Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2007;32:435-439. (Pubitemid 47223713)
3. Matsuguma H, Nakahara R, Igarashi S, Ishikawa Y, Suzuki H, Miyazawa N, Honjo S, Yokoi K. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis. J Thorac Cardiovasc Surg 2008;135:44-49.
4. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K, American College of Chest Physicians. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):234S-242S.
5. International Union Against Cancer. Lung tumours. In: Sobin LH, Wittekind CH, editors. TNM classification of malignant tumours. 6th edition. New York: Wiley-Liss; 2002.
6. Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 2009;15:4-9.
7. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumors, World Health Organization International Histological Classification of Tumors. Berlin: Springer; 1999.
8. Sawabata N. Discrepancy in serum carcinoembryonic antigen levels by measuring kits. Ann Thorac Surg 2003;75:973-980.
9. Stevens DP, Mackay IR. Increased carcinoembryonic antigen in heavy cigarette smokers. Lancet 1973;2:1238-1239.
10. Cox G, Jones JL, Andi A, Waller DA, O'Byrne KJ. A biological staging model for operable non-small cell lung cancer. Thorax 2001;56:561-566. (Pubitemid 32588536)